• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人C1抑制剂的蛋白水解和去糖基化。对功能特性的影响。

Proteolysis and deglycosylation of human C1 inhibitor. Effect on functional properties.

作者信息

Reboul A, Prandini M H, Colomb M G

机构信息

Laboratoire d'Immunochimie-CEN-G, INSERM U238, unité alliée CNRS, USTMG, Grenoble, France.

出版信息

Biochem J. 1987 May 15;244(1):117-21. doi: 10.1042/bj2440117.

DOI:10.1042/bj2440117
PMID:3311024
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1147961/
Abstract

The effects of proteolysis and deglycosylation on C1 inhibitor (C1Inh) were tested with respect to both its ability to form complexes with C1s and its capacity to block C1 autoactivation. Limited proteolysis of C1Inh by Staphylococcus aureus V8 proteinase, proline-specific endopeptidase or elastase generated a major high-Mr (approximately 86,000) fragment. In contrast with the fragment produced by elastase, which was inactive, the fragments resulting from V8 proteinase and proline-specific endopeptidase treatment retained activity. Deglycosylation with N-glycanase or O-glycanase, or both, had no major effect on the functional activity of C1Inh.

摘要

就其与C1s形成复合物的能力及其阻断C1自激活的能力而言,测试了蛋白水解和去糖基化对C1抑制剂(C1Inh)的影响。金黄色葡萄球菌V8蛋白酶、脯氨酸特异性内肽酶或弹性蛋白酶对C1Inh进行有限的蛋白水解产生了一个主要的高分子量(约86,000)片段。与弹性蛋白酶产生的无活性片段相反,V8蛋白酶和脯氨酸特异性内肽酶处理产生的片段保留了活性。用N-聚糖酶或O-聚糖酶或两者进行去糖基化对C1Inh的功能活性没有重大影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4be/1147961/2f35d8c06d92/biochemj00255-0119-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4be/1147961/db5becc93439/biochemj00255-0119-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4be/1147961/2f35d8c06d92/biochemj00255-0119-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4be/1147961/db5becc93439/biochemj00255-0119-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4be/1147961/2f35d8c06d92/biochemj00255-0119-b.jpg

相似文献

1
Proteolysis and deglycosylation of human C1 inhibitor. Effect on functional properties.人C1抑制剂的蛋白水解和去糖基化。对功能特性的影响。
Biochem J. 1987 May 15;244(1):117-21. doi: 10.1042/bj2440117.
2
Enzymatic inactivation of human plasma C1-inhibitor and alpha 1-antichymotrypsin by Pseudomonas aeruginosa proteinase and elastase.铜绿假单胞菌蛋白酶和弹性蛋白酶对人血浆C1抑制剂及α1抗糜蛋白酶的酶促失活作用
Biochim Biophys Acta. 1984 Aug 28;789(1):37-43. doi: 10.1016/0167-4838(84)90057-8.
3
C1 subcomponent complexes: basic and clinical aspects.C1亚成分复合物:基础与临床方面
Behring Inst Mitt. 1993 Dec(93):292-8.
4
A common neoepitope is created when the reactive center of C1-inhibitor is cleaved by plasma kallikrein, activated factor XII fragment, C1 esterase, or neutrophil elastase.当C1抑制剂的反应中心被血浆激肽释放酶、活化的因子XII片段、C1酯酶或中性粒细胞弹性蛋白酶切割时,会产生一种常见的新表位。
J Clin Invest. 1988 Aug;82(2):700-5. doi: 10.1172/JCI113650.
5
Expression of functional human C1 inhibitor in COS cells.功能性人C1抑制剂在COS细胞中的表达。
J Biol Chem. 1988 Aug 25;263(24):11776-9.
6
Proteolytic cleavage and inactivation of alpha 2-plasmin inhibitor and C1 inactivator by human polymorphonuclear leukocyte elastase.人多形核白细胞弹性蛋白酶对α2-纤溶酶抑制剂和C1灭活剂的蛋白水解切割与灭活作用。
J Biol Chem. 1982 Aug 25;257(16):9849-54.
7
[A simplified method for the assessment of C1 esterase inhibitor function].[一种评估C1酯酶抑制剂功能的简化方法]
Ryumachi. 1990 Jun;30(3):166-71.
8
Biosynthesis of complement C1 inhibitor by Hep G2 cells. Reactivity of different glycosylated forms of the inhibitor with C1s.Hep G2细胞对补体C1抑制因子的生物合成。该抑制因子不同糖基化形式与C1s的反应性。
Biochem J. 1986 Jul 1;237(1):93-8. doi: 10.1042/bj2370093.
9
Mechanism of action of anti-C1-inhibitor autoantibodies: prevention of the formation of stable C1s-C1-inh complexes.抗C1抑制物自身抗体的作用机制:阻止稳定的C1s-C1抑制物复合物的形成。
Mol Med. 1998 Feb;4(2):119-28.
10
Activation of human complement serine-proteinase C1r is down-regulated by a Ca(2+)-dependent intramolecular control that is released in the C1 complex through a signal transmitted by C1q.人补体丝氨酸蛋白酶C1r的激活通过一种Ca(2+)依赖性分子内调控被下调,这种调控在C1复合物中通过C1q传递的信号被释放。
Biochem J. 1994 Jul 15;301 ( Pt 2)(Pt 2):509-16. doi: 10.1042/bj3010509.

引用本文的文献

1
Anticoagulant SERPINs: Endogenous Regulators of Hemostasis and Thrombosis.抗凝血丝氨酸蛋白酶抑制剂:止血和血栓形成的内源性调节因子。
Front Cardiovasc Med. 2022 May 3;9:878199. doi: 10.3389/fcvm.2022.878199. eCollection 2022.
2
A New Tool for Complement Research: Reconstituted Human Classical Complement Pathway.补体研究的新工具:重建人经典补体途径。
Front Immunol. 2018 Dec 4;9:2770. doi: 10.3389/fimmu.2018.02770. eCollection 2018.
3
N- and -glycosylation Analysis of Human C1-inhibitor Reveals Extensive Mucin-type -Glycosylation.

本文引用的文献

1
A BIOCHEMICAL ABNORMALITY IN HEREDIATRY ANGIONEUROTIC EDEMA: ABSENCE OF SERUM INHIBITOR OF C' 1-ESTERASE.遗传性血管神经性水肿中的一种生化异常:血清C1酯酶抑制剂缺失
Am J Med. 1963 Jul;35:37-44. doi: 10.1016/0002-9343(63)90162-1.
2
Size and shape of human C1-inhibitor.人C1抑制物的大小和形状。
FEBS Lett. 1981 Aug 31;131(2):283-5. doi: 10.1016/0014-5793(81)80385-7.
3
A new role for C-1-inhibitor in homeostasis: control of activation of the first component of human complement.C1抑制剂在体内平衡中的新作用:对人类补体第一成分激活的控制
人 C1 抑制剂的 N-和 -糖基化分析揭示了广泛的粘蛋白型糖基化。
Mol Cell Proteomics. 2018 Jun;17(6):1225-1238. doi: 10.1074/mcp.RA117.000240. Epub 2017 Dec 12.
4
N-linked glycosylation at Asn3 and the positively charged residues within the amino-terminal domain of the c1 inhibitor are required for interaction of the C1 Inhibitor with Salmonella enterica serovar typhimurium lipopolysaccharide and lipid A.C1抑制剂与鼠伤寒沙门氏菌脂多糖和脂质A相互作用需要C1抑制剂Asn3处的N-连接糖基化以及氨基末端结构域内的带正电荷残基。
Infect Immun. 2005 Aug;73(8):4478-87. doi: 10.1128/IAI.73.8.4478-4487.2005.
5
Metabolic alteration of the N-glycan structure of a protein from patients with a heterozygous protein deficiency.杂合性蛋白质缺乏症患者蛋白质N-聚糖结构的代谢改变。
Biochim Biophys Acta. 2004 Dec 24;1739(1):43-9. doi: 10.1016/j.bbadis.2004.08.006.
6
N-linked glycosylation is required for c1 inhibitor-mediated protection from endotoxin shock in mice.N-连接糖基化对于C1抑制剂介导的小鼠内毒素休克保护作用是必需的。
Infect Immun. 2004 Apr;72(4):1946-55. doi: 10.1128/IAI.72.4.1946-1955.2004.
7
Dysfunctional C1 inhibitor Ta: deletion of Lys-251 results in acquisition of an N-glycosylation site.功能失调的C1抑制剂Ta:赖氨酸-251的缺失导致一个N-糖基化位点的获得。
Proc Natl Acad Sci U S A. 1990 Sep;87(17):6786-90. doi: 10.1073/pnas.87.17.6786.
J Immunol. 1982 Jun;128(6):2505-8.
4
Proteolytic cleavage and inactivation of alpha 2-plasmin inhibitor and C1 inactivator by human polymorphonuclear leukocyte elastase.人多形核白细胞弹性蛋白酶对α2-纤溶酶抑制剂和C1灭活剂的蛋白水解切割与灭活作用。
J Biol Chem. 1982 Aug 25;257(16):9849-54.
5
Proline-specific endopeptidase from Flavobacterium. Purification and properties.来自黄杆菌的脯氨酸特异性内肽酶。纯化及性质
J Biol Chem. 1980 May 25;255(10):4786-92.
6
Angiotensinogen is related to the antitrypsin-antithrombin-ovalbumin family.血管紧张素原与抗胰蛋白酶-抗凝血酶-卵清蛋白家族相关。
Science. 1983 Oct 28;222(4622):417-9. doi: 10.1126/science.6604942.
7
Enzymatic inactivation of human plasma C1-inhibitor and alpha 1-antichymotrypsin by Pseudomonas aeruginosa proteinase and elastase.铜绿假单胞菌蛋白酶和弹性蛋白酶对人血浆C1抑制剂及α1抗糜蛋白酶的酶促失活作用
Biochim Biophys Acta. 1984 Aug 28;789(1):37-43. doi: 10.1016/0167-4838(84)90057-8.
8
Diamine-induced dissociation of the first component of human complement, C1.二胺诱导人补体第一成分C1的解离
Eur J Biochem. 1984 Apr 16;140(2):421-6. doi: 10.1111/j.1432-1033.1984.tb08119.x.
9
Human C1 inhibitor: improved isolation and preliminary structural characterization.人C1抑制剂:改进的分离方法及初步结构表征
Biochemistry. 1983 Oct 11;22(21):5001-7. doi: 10.1021/bi00290a019.
10
Biosynthesis in vitro of complement subcomponents C1q, C1s and C1 inhibitor by resting and stimulated human monocytes.静息和刺激的人单核细胞对补体亚成分C1q、C1s和C1抑制剂的体外生物合成
Biochem J. 1983 Nov 15;216(2):385-92. doi: 10.1042/bj2160385.